Aceclofenac 200mg + Rabeprazole 20mg Capsules are a pharmaceutical combination formulation containing Aceclofenac and Rabeprazole as active pharmaceutical ingredients. Each capsule contains Aceclofenac 200mg and Rabeprazole 20mg, presented in a suitable oral solid dosage form.
The development of a combination capsule requires careful consideration of the characteristics of both active ingredients, including their compatibility, stability, solubility, particle properties, and interaction with formulation excipients. Pharmaceutical scientists evaluate these parameters during product development to establish an appropriate formulation and manufacturing process.
Capsule formulations also require attention to filling accuracy, uniformity, shell compatibility, moisture control, and product stability. A controlled manufacturing approach helps maintain consistency across different production batches.
From raw-material procurement to final packaging, each stage is carried out according to predefined pharmaceutical specifications and quality procedures.
The formulation consists of Aceclofenac 200mg and Rabeprazole 20mg. Both active pharmaceutical ingredients are incorporated into the capsule according to their specified strengths.
Because the two ingredients can possess different physical and chemical properties, formulation development involves evaluating their individual characteristics before selecting suitable excipients and processing methods. Factors such as particle size, flowability, moisture sensitivity, solubility, and stability may influence the final formulation.
Depending on the product design, suitable pharmaceutical excipients may be used to improve powder flow, uniformity, filling characteristics, and physical stability. The formulation process is optimized to achieve consistent distribution of the required ingredients.
Particular attention can also be given to the stability characteristics of Rabeprazole during formulation and packaging. Appropriate formulation and packaging strategies are important for maintaining the defined quality characteristics of the finished product throughout its specified shelf life.
Manufacturing Aceclofenac 200mg + Rabeprazole 20mg Capsules involves a sequence of controlled pharmaceutical operations. The process generally begins with the testing and approval of pharmaceutical-grade raw materials.
Approved ingredients are dispensed according to the batch formula and processed using suitable manufacturing techniques. Depending on the formulation design, the ingredients may undergo processes such as sifting, blending, granulation, drying, lubrication, and other controlled operations before capsule filling.
Capsule filling requires accurate control of fill weight and material distribution. In-process checks can be performed to monitor parameters such as blend uniformity, moisture content, fill weight, capsule appearance, and overall production consistency.
For formulations containing ingredients with different characteristics, manufacturing controls become particularly important. Appropriate process optimization helps achieve uniformity and reproducibility during commercial-scale production.
Following filling, capsules may undergo inspection and quality testing before being released for packaging.
Quality evaluation is an essential part of the development and manufacturing of Aceclofenac 200mg + Rabeprazole 20mg Capsules. Both raw materials and finished products are evaluated according to established specifications.
Finished capsules may be examined for appearance, average fill weight, weight variation, assay, content uniformity, disintegration, dissolution-related parameters, and other applicable quality attributes.
Analytical testing is especially important for combination formulations because the individual active ingredients need to be accurately identified and quantified. Suitable analytical methods help verify the specified levels of Aceclofenac and Rabeprazole within the finished product.
Stability studies may also be conducted under defined storage conditions. These evaluations help manufacturers understand changes in physical and chemical characteristics over time and support the establishment of appropriate product specifications.
Batch documentation, laboratory reports, raw-material records, and manufacturing records provide traceability throughout the production process. Together, these quality systems help maintain consistency between manufacturing batches.
Packaging plays a significant role in maintaining the quality of Aceclofenac 200mg + Rabeprazole 20mg Capsules during storage, transportation, and distribution. The packaging system is selected based on the characteristics of the formulation and its stability requirements.
Suitable primary packaging can provide protection against relevant environmental conditions, while secondary packaging supports product identification and transportation. Packaging materials may be selected with particular consideration for moisture and environmental protection where required by the formulation.
Accurate product labeling is also essential. Packaging generally contains information such as the product name, composition, individual strengths, batch number, manufacturing details, expiry information, manufacturer information, and other applicable regulatory particulars.
Professional packaging contributes not only to product protection but also to pharmaceutical brand identity. Consistent packaging formats across a company's product range can create a more recognizable and organized portfolio.
Aceclofenac 200mg + Rabeprazole 20mg Capsules can be included in a diversified pharmaceutical portfolio containing combination formulations and different oral solid dosage forms.
For pharmaceutical manufacturers, distributors, franchise businesses, and marketing organizations, developing a balanced product portfolio involves considering several factors such as formulation quality, manufacturing capabilities, packaging standards, documentation, supply reliability, and product consistency.
Combination capsules can add variety to a company's existing range while allowing businesses to offer formulations containing established pharmaceutical ingredients. A well-structured portfolio can include products across multiple dosage forms and formulation categories.
Reliable manufacturing and consistent supply are important for maintaining product availability across different markets. Proper production planning, quality-release procedures, inventory management, and packaging controls can support an efficient pharmaceutical supply chain.
A quality-focused approach is important throughout the complete lifecycle of Aceclofenac 200mg + Rabeprazole 20mg Capsules. It begins with pharmaceutical-grade raw materials and continues through formulation development, manufacturing, analytical evaluation, packaging, storage, and distribution.
Controlled production processes help maintain the specified composition and physical characteristics of the capsules. Quality-control procedures can evaluate important parameters such as active-ingredient assay, content uniformity, fill weight, dissolution characteristics, physical appearance, and stability.
For this combination formulation, appropriate attention to ingredient compatibility, moisture control, formulation uniformity, capsule filling accuracy, analytical testing, stability, and packaging integrity can contribute to consistent product quality.
We combine quality, innovation, and strong distribution to help our partners grow successfully in the pharma market.
The company is offering business opportunity for scalable and sustainable returns to its associates. We are engaged in discovery, development and commercialization of pharmaceutical medicine keeping in mind its quality and affordability.
© Novolilly 2025. All Rights Reserved – Developed & Managed By Kavir Infotech